About clot management devices
A blood clot or thrombus is the end stage of blood coagulation process in hemostasis. Blood clot is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormally to obstruct blood flow through healthy blood vessels. This condition is called thrombosis. A blood clot in arteries can lead to heart attack, while blood clot formed in the deep veins can lead to DVT or PE. Clot management devices help in the removal of a clot or dissolving clot in the blood vessels.
Technavio's analysts forecast the global clot management devices market to grow at a CAGR of 5.95 percent over the period 2014-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global clot management devices market for the period 2015-2019. Based on type of devices, the market can be segmented as follows: percutaneous thrombectomy devices, embolectomy balloon catheters, catheter-directed thrombolysis, IVCF, and neurovascular embolectomy devices.
Technavio's report, the Global Clot Management Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global clot management devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• AngioDynamics
• Boston Scientific
• Cook Group
• Stryker
Other prominent vendors
• Acandis
• Argon Medical Devices
• Asid Bonz
• Biosensors International Group
• Control Medical Technology
• Covidien
• DePuy Synthes
• Dispomedica
• Edwards Lifesciences
• EKOS (a BTG International Group company)
• Eurocor
• FBMedical-ISOMed
• iVascular
• LeMaitre Vascular
• Merit Medical
• Phenox
• Straub Medical
• Teleflex
Market driver
• Growing awareness of endovascular treatment
• For a full, detailed list, view our report
Market challenge
• Acceptance of anticoagulant therapy
• For a full, detailed list, view our report
Market trend
• Increase in number of MIS procedures
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
05.1 Risk factors associated with blood clots
05.2 Epidemiology of VTE
05.3 Pathophysiology of VTE
05.4 Blood clot by type
06. Market Landscape
06.1 Market overview
06.2 Market size and forecast
06.3 Five forces analysis
07. Market Segmentation by Device
08. Geographical Segmentation
09. Americas
09.1 Market size and forecast
10. EMEA
10.1 Economic burden of VTE following major orthopedic surgery in Europe
10.2 Market size and forecast
11. APAC
11.1 Market size and forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2013
19.3 Other prominent vendors
20. Key Vendor Analysis
20.1 AngioDynamics
20.1.1 Key facts
20.1.2 Business overview
20.1.3 Business segmentation
20.1.4 Business strategy
20.1.5 Revenue segmentation by category of product
20.1.6 Revenue segmentation by geography
20.1.7 Key information
20.1.8 SWOT analysis
20.2 Boston Scientific
20.2.1 Key facts
20.2.2 Business Overview
20.2.3 Business segmentation
20.2.4 Business segmentation by revenue 2013
20.2.5 Business segmentation by revenue 2012 and 2013
20.2.6 Geographical segmentation by revenue 2013
20.2.7 Business strategy
20.2.8 Key developments
20.2.9 SWOT analysis
20.3 Cook Medical
20.3.1 Key facts
20.3.2 Business overview
20.3.3 Key divisions
20.3.4 Geographical segmentation 2013
20.3.5 Business strategy
20.3.6 Recent developments
20.3.7 SWOT analysis
20.4 Stryker
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2013
20.4.4 Business segmentation by revenue 2012 and 2013
20.4.5 Geographical segmentation by revenue 2013
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
21.Other Reports in this Series
List of Exhibts:
Exhibit 1: Market research methodology
Exhibit 2: Risk factors associated with blood clots
Exhibit 3: VTE incidences in US
Exhibit 4: Other incidences
Exhibit 5: Types of blood clot
Exhibit 6: Risk factors for DVT
Exhibit 7: Risk factors for PE
Exhibit 8: Global clot management devices market 2014-2019 ($ million)
Exhibit 9: Segmentation by device
Exhibit 10: Segmentation of global clot management devices market by geography 2014
Exhibit 11: Clot management devices market 2014-2019 ($ million)
Exhibit 12: VTE disease burden in Europe
Exhibit 13: Total number of VTE events per year within six European countries
Exhibit 14: Relative distribution of diagnosed and undiagnosed PE among fatal VTE events
Exhibit 15: Clot management devices market 2014-2019 ($ million)
Exhibit 16: Clot management devices market 2014-2019 ($ million)
Exhibit 17: Segmentation of global clot management devices market by geography 2014-2019
Exhibit 18: Segmentation of global clot management devices market by geography 2014-2019 ($ million)
Exhibit 19: Segmentation of global clot management devices market by geography 2014 and 2019
Exhibit 20: Segmentation of global clot management devices market by geography 2014 and 2019 ($ million)
Exhibit 21: Endovascular treatment of stroke
Exhibit 22: Clinical evidence
Exhibit 23: AngioDynamics: business segmentation by category of product
Exhibit 24: AngioDynamics: segmentation of revenue by category of product 2014
Exhibit 25: AngioDynamics: segmentation of revenue by geography 2014
Exhibit 26: Boston Scientific: business segmentation 2013
Exhibit 27: Boston Scientific: business segmentation by revenue 2013
Exhibit 28: Boston Scientific: business segmentation by revenue 2012 and 2013 ($ million)
Exhibit 29: Boston Scientific: geographical segmentation by revenue 2013
Exhibit 30: Cook Medical: key divisions
Exhibit 31: Cook Medical: geographical segmentation 2013
Exhibit 32: Stryker: business segmentation by revenue 2013
Exhibit 33: Stryker: business segmentation by revenue 2012 and 2013 ($ million)
Exhibit 34: Stryker: geographical segmentation by revenue 2013
